By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Vancouver  British Columbia    Canada
Phone: n/a Fax: n/a


CEO: Mary Szela

Key Statistics

Ownership: Public

Web Site: Novelion
Symbol: AEGR

Company News
Novelion (AEGR) CEO Steps Down From Novo Nordisk A/S (NVO) Board Due To NASH Conflict 5/16/2017 10:32:22 AM
Novelion (AEGR) Reports First Quarter 2017 Financial Results 5/9/2017 10:32:52 AM
Novelion (AEGR) Announces Presentation Of Metreleptin Data At American Association of Clinical Endocrinologists 5/5/2017 9:02:14 AM
Novelion (AEGR)’ Request To Voluntarily Delist From The Toronto Stock Exchange Granted 4/20/2017 10:22:57 AM
Novelion (AEGR) Release: Metreleptin And Lipodystrophy Data Presented At The Annual Meeting Of The Endocrine Society 4/5/2017 11:34:41 AM
Novelion (AEGR) Appoints Mark Corrigan, M.D. To Board Of Directors 3/31/2017 9:46:00 AM
Novelion (AEGR) Reports Preliminary Fourth Quarter & Full Year 2016 Financial Results 3/15/2017 8:36:27 AM
Novelion (AEGR) To Announce Preliminary Fourth Quarter And Full Year 2016 Financial Results On March 15, 2017 3/14/2017 10:53:36 AM
Novelion (AEGR) Release: U.S. Patent Trial And Appeal Board Affirms Lomitapide Patents With Favorable IPR Decisions 3/7/2017 8:45:40 AM
Novelion (AEGR) Release: Biotech Announces Acceptance Of Marketing Authorization Application For Metreleptin By EMA 1/23/2017 6:52:24 AM